安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Camzyos: Uses, Dosage, Side Effects Warnings - Drugs. com
Camzyos is a cardiac myosin inhibitor that relaxes heart muscles so the heart can fill with more blood and pump blood around your body more effectively In obstructive hypertrophic cardiomyopathy (HCM), the walls of the heart become excessively thickened and stiff
- CAMZYOS® (mavacamten) Patient Site
CAMZYOS is a prescription medicine used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) CAMZYOS may improve your symptoms and your ability to be active It is not known if CAMZYOS is safe and effective in children CAMZYOS ® is approved for adults 18 and older
- Mavacamten - Wikipedia
Mavacamten, sold under the brand name Camzyos, is a medication used to treat obstructive hypertrophic cardiomyopathy [7][8] Mavacamten is a small-molecule allosteric [9] cardiac myosin inhibitor [7]
- Camzyos (mavacamten) - Uses, Side Effects, and More
Camzyos (mavacamten) is commonly used for symptomatic obstructive hypertrophic cardiomyopathy (HCM) HCM is a heart condition where the heart muscle thickens over time, which makes it harder for
- About CAMZYOS® (mavacamten) - Symptomatic Obstructive HCM Treatment
CAMZYOS is a first-in-class treatment* for symptomatic obstructive HCM that helps improve your symptoms and your ability to be active *CAMZYOS is the first FDA-approved cardiac myosin inhibitor
- Camzyos: Price, Side Effects, How It Works, Uses, and More
Camzyos (mavacamten) is a prescription capsule that treats obstructive hypertrophic cardiomyopathy in adults Learn about price, side effects, and more
- CAMZYOS U. S. Prescribing Information - BMS
The efficacy of CAMZYOS was evaluated in VALOR-HCM, a Phase 3, double-blind, randomized, 16-week, placebo-controlled trial in 112 patients (mean age of 60 years; 51% men; 93% ≥NYHA class III) randomized 1:1 to receive treatment with CAMZYOS or placebo
- Approval Label_214998s010lbl
Because of the serious risk of heart failure, CAMZYOS is only available through a restricted program called the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program
|
|
|